EZH2's role in regulating GFAP expression and astrocyte differentiation is of great interest, as it may offer insights into the molecular foundation of glioma formation and potential therapeutic strategies [18, 19, 20]. The gene discussed is EZH2; the disease is central nervous system cancer.